M. A. Cortes

SHP-1 in cell-cycle regulation.

J. Rodríguez-Ubreva, B. Colás, Ariel E. Cariaga, 2011, Anti-cancer agents in medicinal chemistry.

SSTR1‐ and SSTR3‐Selective Somatostatin Analogues

P. Martin-Malpartida, B. Ponsati, J. Fernández-Carneado, 2011, Chembiochem : a European journal of chemical biology.

Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery

S. Ropero, A. Cariaga-Martínez, B. Colás, 2010, Oncogene.

Insights into Structure-Activity Relationships of Somatostatin Analogs Containing Mesitylalanine

M. Macias, P. Martin-Malpartida, E. Aragón, 2013, Molecules.

EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.

J. Angulo, M. V. Lobo, A. Cariaga-Martínez, 2012, Carcinogenesis.

Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.

J. Rodríguez-Ubreva, Ana González-Corpas, Javier Rodriguez-Ubreva, 2013, Cellular signalling.

EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt.

S. Ropero, R. Colomer, B. Colás, 2007, Neoplasia.